One of the many complications of osteoporosis is compromised biomechanical integrity of the spine and fractures. Spinal fusion, is a common surgical procedure for osteoporotic patients.
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Introduction
Osteoporosis is a common skeletal disease characterized by low bone mineral density (BMD) and micro-architectural deterioration of bone tissue. There are degenerative changes that accompanies osteoporosis in the intervertebral discs and spinal facet joint capsules in people over 50 years of age resulting in spinal instability and the ultimate outcome of fragility fractures.
Because osteoporosis is strongly associated with poor fusion rate and bone stability, it is crucial to understand the pathophysiology of osteoporosis and its treatment, in order to enhance spinal fusion and preserve bone stability.
Pathogenesis of Postmenopausal Osteoporosis
Bone is comprised of a collection of dynamic tissues. Bone remodeling which is a process of controlled bone resorption and formation occurs in the bone microcracks continuously (14, 16) .
It's carried out by basic multicellular unit (BMU) within the bone remodeling cavity, and the BMU is composed of osteoclasts, osteoblasts, bone lining cells and osteocytes (20) . Complete regeneration of adult skeleton takes 10 years through remodeling to repair damage and prevent aging and fracture (14) . Disruption of the remodeling process with increased osteoclastic activity results in reduced bone mineral density (BMD) and osteoporosis. Among several etiologies of osteoporosis, menopause is considered the most common one. Bone loss both in men and women commence in the 40's and accelerated bone loss occurs in women during 1 st -10 th year after menopause.
Therefore, the incidence of fracture is higher in women than men (18) .
Loss of estrogen in menopause has several effects on bone biology. Molecular changes occur which involves increased secretion of IL-1, IL-6, macrophage colony stimulating factor and TNF.
These cytokines stimulate osteoclast development. Moreover, loss of the inhibitory effects of Osteoprotegerin, which is stimulated by estrogen, on osteoclastogenesis come about.
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Osteoprotegerin acts by blocking the receptor activation of nuclear factor-kB (RANK)ligand/RANK interaction--the main stimulator of osteoclast differentiation and activation. Nonetheless, cellular changes in menopause favors increased osteoclast formation which tends to persists with decreased initial mesenchymal differentiation towards osteoblasts.
Estrogen deficiency leads to shorter osteoblast and osteocytes life span, and prolongation of osteoclast lifespan (17, 19) . These events will impair osteocyte-canalicular mechanoreceptors which act as skeletal signals for detection of micro-damage and repair with eventual bone loss as a downstream consequence to these changes.
Osteoporosis and Fragility, definition and prevalence
Today osteoporosis is defined as loss of bone mass and micro architectural deterioration of the bone tissue with subsequent bone fragility and increased fracture risk (1) . (2) .
The risk of sustaining a fragility fracture approximately doubles with each SD reduction in the BMD score, 2.6 times the risk for fracture of the femoral neck and 2.3 times for vertebral fracture (3, 4) . Vertebral fractures are a common cause of morbidity with a prevalence of 15-20% in postmenopausal women and often associated with significant prolonged pain (23, 24) . Worldwide it is estimated that one in three women and one in five men that will suffer a fragility fracture after the age of 50 years (25) . Alongside the suffering of the fracture patient, osteoporosis and subsequent fractures are a major burden to healthcare costs worldwide (26) with at least 250,000 spinal fusion surgeries performed in the United States each year (52) . 3
Age-Related marrow adipogenesis and healing capacity in osteoporosis
Age-related increase in adipogenesis in the bone marrow further leads to decreased osteoblastogenesis (36, 38) as osteoblasts and adipocytes are derived from the same BMSCs.
Subsequently, there is a natural decline in the number of osteoblasts due to aging, and literature has shown a decrease in their function and survival as well (37) . For these reasons, the biologic response to even the commonly used bone substitutes are suboptimal in such patients, in terms of efficacy and efficiency of bone regeneration and the frequency and magnitude of unwanted side effects (13) . As one of the many complications of osteoporosis is a compromised biomechanical integrity of the spine leading to limited motion and weight bearing function of the spine. Often such bone degeneration results in compression of the nerve roots, or even the spinal cord. The goal of spinal fusion surgery is to support the spine, prevent progression of deformity, and alleviate or eliminate pain. In elderly patients, iatrogenic cause of instability following spinal surgery may occur because of pre-existing degenerative changes in the facet joints and intervertebral disc.
Moreover, achieving secure spinal fusion in osteoporotic patients with alternative therapies remains difficult due to reduced stem cell function and increased adipogenesis. In elderly osteoporotic patients, non-union occurred in 5 to 35% of patients who underwent spinal fusion (8, 11) . For these reasons a thorough understanding the spinal fusion biology is crucial.
Spinal Fusion Biology
Clinically relevant lumbar fusion animal models in previous literature provided information on the methods that facilitated fusion. Non-decortication of the transverse process did not result in arthrodesis as the primary vascular supply to the fusion mass originated from the decorticated bone, and not from the adjacent muscle (9, 21) . Following spinal fusion surgeries and insertion of the graft material, intramembranous bone formation occurred in the area adjacent to 4 the transverse processes while endochondral bone formation occurs centrally at the interface between the upper and lower halves of the bridging bone (39) . Cartilage formed from endochondral ossification has poor vascular supply and low oxygen saturation. In mid-and late stages of bone formation, bone extends towards the central zone with disappearance of cartilage (9, 10, 21) . The transient cartilageous area may explain lack of union that is found in central zones of a fusion mass (40) . Considering previously stated factors for a successful fusion, osteoinductive materials, osteoconductive scaffold and osteogenic cells are needed.
Spinal Fusion graft materials and Pharmacotherapeutic strategies
As bone formation is a coupled process between osteoblasts and osteoclasts maintaining homeostasis within bone, resorptive agents that induce osteoclasts apoptosis might not be effective in spinal fusion surgeries which necessitates new bone formation. Subsequently, the gold standard for spinal fusion surgeries is harvesting autologous cortical and cancellous bone from the iliac crest due to the presence of the three fundamental properties for a successful fusion (osteogenicity, osteoconductivity, and osteoinductivity) with eventual bonding of the graft material to the host bone (osteointegration). Osteoprogenitor cells living in the donor graft may survive during implantation with potential proliferation and differentiation to osteoblasts and eventually osteocytes. These cells represent the "osteogenic" potential of the graft (75, 76) . "Osteoinduction" of the graft material, on the other hand, is the ability to stimulate and activate the host mesenchymal stem cells from surrounding tissue to differentiate into osteoblasts. This process is mediated by a cascade of signals and activations of several extra-and intracellular receptors, most importantly related to TGF-beta super-family (75, 76) . Any graft material which can serve as a scaffold for the ingrowth of new bone and facilitation of vasculogenesis with orientation of the blood-vessels into a new Haversian system, provide an "osteoconduction" capability to the graft (74, 76) , which can also be considered as graft extenders (carriers).
Although autografts have the 3 essential features for a successful grafting material, these grafts are limited in quantity and include donor-site morbidity (45, (46) (47) (48) . Therefore, other several methods of bone reconstruction and regeneration were developed namely using allograft, demineralized bone matrix (DBX), hydroxyapatite calcium phosphate (CP, TCP), autologous bone marrow aspirates, bone morphogenic proteins (BMPs), and several other related growth factors (VEGF, PDGF, etc.). However, all these other forms of bone grafts have disadvantages when compared to autologous bone graft and as such their suboptimal use (79) . For example, when bone marrow mesenchymal cells (BMSCs) have been studied for skeletal engineering applications, results showed that BMSCs have limitations, including limited autogenous supply of bone marrow aspirate, and relatively lower cell yield of BMSCs with increased risk of immunogenicity, genetic instability, and infection in in-vitro cell culture (49) (50) (51) (72) (73) . CP and β-TCP have a little osteoconduction potential and thus used more as bone extenders (carriers) to be combined with other osteoinductive and osteogenic molecules (77, 78) . within few passages (80) . However, BMSCs have been reported to require selective sera and other growth factors for their expansion (81) . Also, patients' morbidity proposes a limitation while procuring BMSCs. Aspirating volumes larger than a few milliliters may be painful and frequently requires general or spinal anesthesia and may yield low numbers of MSCs upon processing (82) . And as samples are highly expanded, these procured BMSCs appeared to lose their differentiation and self-renewal capacity and approach senescence and/or express apoptotic features (83, 84) . This process is further complicated in osteoporotic patients due to increased adipogenesis. Although aging has negative effects on the number of osteoblasts, it has a positive effect on the number of adipogenesis and the formation of fatty marrow.
Human Perivascular Stem
In attempt to circumvent the limitations of BMSCs, research has been directed to find alternative sources to MSCs. Literature has shown adipose tissue as a promising source of MSCs.
Adipose tissue is highly accessible and abundant. The cell pellet obtained after processing of the liposapirate is called stromal vascular fraction (SVF). Adipose-derived stem cells (ASCs) was found to be at least three folds higher than BMSCs based on colony-forming unit adherent cells which comprised 3% of the SVF population (85, 86) . A single milliliter of liposuction tissue aspirate can generate one-quarter a million ASCs through a single passage with an expansion of 64-fold with a 26-day period (85) . Although SVF provided significantly higher mesenchymal stem cells number and quality with less surgical risks. The SVF is well recognized to be a heterogenous population including non-stem cells, such as inflammatory, hematopoietic, and endothelial cells, which results in unreliable bone formation (49) (50) (51) 73) . With these drawbacks of currently available sources of MSC, there exists a clinical need for reliable MSC source with proven safety, purity, identity, and efficacy.
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Our laboratory has identified and isolated perivascular stem cells (PSC) from adipose tissue using a fluorescence-activated cell sorting (FACS) method (27) (28) (29) (30) . PSC are identified by their cell surface markers and include pericytes from microvessels and capillaries (which are CD34-, CD146+, CD45-), and adventitial cells from larger arteries and veins (which are CD34+, CD146-, CD45-) (33) . PSC exhibit the characteristic surface markers and clonal multilineage differentiation potential of MSC (27) (28) (29) (30) . The evidence supporting the use of human perivascular stem cells (hPSC)
for bone tissue engineering is based on our previous studies; including pancreas-and other organderived human pericytes resulted in robust in vitro osteogenic differentiation and intramuscular bone formation and angiogenesis (66) ; adipose-derived hPSC form significantly increased intramuscular bone compared to patient-matched unpurified cells and demonstrate in vivo trophic and angiogenic effects (43, 87) ; as well as exhibited osteoprogenitor (34) and chondroprogenitor (35) cell types. This was accompanied by increased expression of bone morphogenic protein 2 (BMP2), BMP7, and vascular endothelial growth factor (VEGF), and resulted in robust bone formation in spinal fusion procedures on non-osteoporotic rats (44) ; and lastly adipose-derived hPSC exhibited improved calvarial bone defect healing as compared to unsorted SVF (88) .
NELL-1 Anti-osteoporotic, and Pro-osteogenic Properties:
Nel-like protein-1 (NELL-1) has been found to induce osseous healing in small and large animal models including osteoporotic rat models without harmful side effects (41, 42) . Interestingly, we observed an additive effect of NELL-1 and human perivascular stem cells (hPSCs) in an ectopic bone formation model (27, 43) . The purpose of this study is to determine the efficacy of hPSCs combined with NELL-1 for enhancing spinal fusion in osteoporotic rats with the goal of ultimately developing an effective and safe therapeutic method using hPSCs and NELL-1 to treat patients with osteoporosis. 
Materials and Methods

Isolation of hPSCs
With the exception of one sample from autopsy, lipoaspirate was obtained from patients with and without osteoporosis undergoing liposuction under IRB exemption ( Table 1 ). The hPSCs consisting of two populations: pericytes (CD146+, CD34-, CD45-) and adventitial cells (CD34+, CD146-, CD45-) were purified as previously described (33) . The lipoaspirate was stored at 4C before processing and processed within 48 h of collection. The human stromal vascular fraction (hSVF) was obtained by collagenase digestion as previously described (33) . Briefly, an equal volume of phosphate buffered saline (PBS) was added to dilute the lipoaspirate. The mixture was then digested with Dulbecco's modified Eagle's medium containing 3.5% bovine serum albumin (BSA, Sigma-Aldrich) and 1mg/ml collagenase type II for 70 min under agitation at 37°C. Next, adipocytes were separated and excluded by centrifugation. The processed hSVF was suspended in red cell lysis buffer (155 mM NH4Cl, 10 mM KHCO3, and 0.1mM EDTA) and incubated for 10 min at room temperature. The incubated hSVF was re-suspended in PBS and 4', 6-diamidino-2-phenylindole (DAPI, Invitrogen) was added to exclude dead cells and filtered through a 70 μm cell filter. The resulting hSVF was immediately processed for hPSC purification. The number of live cells was calculated by trypan blue staining.
In vitro assays for osteogenesis and adipogenesis of hPSCs
The hPSCs were cultured in osteogenic or adipogenic differentiation medium containing NELL-1, or phosphate buffered saline (PBS) to compare their effects on osteogenesis and adipogenesis of hPSCs (27) . To induce osteoporosis, 41 athymic rats were ovariectomized (53) . Induction of osteoporosis was confirmed by dual energy X-ray absorptiometry 4 weeks post-OVX. Posterolateral lumbar spinal fusion was performed on n= 41, 8 week old athymic rats as previously described (54) . Rats were anesthetized using isoflurane (5% induction, 2-3% maintenance). After anesthesia induction by isoflurane inhalation, the surgical site was shaved and prepped. A posterior midline incision was made over the skin of the caudal portion of the lumbar spine. Two separate paramedian fascial incisions were made 3 mm from the midline. The transverse processes of the L4 and L5 vertebrae were exposed by blunt muscle splitting technique separating the back muscles. Subsequently, decortication of the transverse processes is carried out using a low speed electric-driven bur until a blush of cancellous bone was observed. Sterile saline irrigation has been used simultaneously during decortication to cool the decorticated site and furnish a clean surface for implantation. Next, one implant per side containing the active drug were placed between the decorticated transverse processes into the paraspinal muscle bed. Fascia and skin incisions were sutured and closed using 4-0 Vicryl absorbable sutures (Ethicon). After surgery, about 0.05 mg/kg buprenorphine was administered twice daily for 2 days postoperatively for analgesia, and 48 mg/mL trimethoprim/sulfamethoxazole antibiotic was administered for 10 days postoperatively. All animals were sacrificed at 4 weeks by CO2 overdose and the spines were harvested for analysis.
Implant preparation
The implants were prepared using 2 different doses of hPSCs and NELL-1 based on our previous studies: (1) Regular dose: 0.25 x 10 6 cells/ml of hPSCs or 33.3 μg/ml of NELL-1 that demonstrated the successful fusion in non-osteoporotic models (44, 54) ; (2) Table 2 .
Manual palpation
Manual palpation was performed to evaluate the fusion mass between the lumbar spines of rats post-harvest. The samples were palpated by three blinded observers and scored on a scale of 1 to 5 by application of flexion and extension forces manually against the L4 and L5 vertebrae as previously described (36) . The scoring criteria is summarized in Table 3 . Scores of four or above were considered as reflective of spinal fusion.
Post-mortem high-resolution microCT evaluation
MicroCT analyses including bone volume (BV) and bone mineral density (BMD) were performed using CT-Analyzer software (SkyScan 1172, Belgium). Animals were sacrificed at 4 weeks post-treatment and harvested for lumbar vertebrae. Samples were fixed in 4% paraformaldehyde (PFA) for 48 hours and stored in 70% EtOH for microCT. Later, EDTA (Ethylenediaminetetraacetic acid) was used for decalcification for histological, and immunohistochemical analyses. Lumbar vertebrae were scanned using a high-resolution microCT (SkyScan 1172, Bruker MicroCT N.V., Kontich, Belgium) at an image resolution of 27.4 µm (55kV and 181 mA radiation source; 0.5-mm aluminum filter). Then, 3D images were reconstructed from the 2D X-ray projections by implementing the Feldkamp algorithm, and appropriate image corrections including ring artifact correction, beam hardening correction, and fine-tuning were processed using NRecon software (SkyScan 1172, Belgium). The dynamic image range (contrast limits) was determined at 0-0.1 in units of attenuation coefficient and applied to all datasets for optimum image contrast.
After acquisition and reconstruction of datasets, images were first reoriented on each 3D plane using DataViewer software (SkyScan 1172, Belgium) to align the long axes of the lumbar vertebrae parallel to coronal and sagittal planes (Fig.1A) . Then, 3D morphometric analyses of the L4 and L5 of lumbar vertebrae were performed using CT-Analyzer software (SkyScan 1172, Belgium). The region of interest was defined as starting from the lower border of transverse process of L5 to the upper border of the transverse process of L4. Region-of-interest (ROIs) were delineated using a freehand drawing tool while maintaining clearance from the cortical boundaries of the transverse process and vertebral body (Fig.1B) . Only graft material and new bone formation between the transverse processes of L4 and L5 were analyzed and quantified (Fig.1C) .
A global threshold of 60-120 was applied to all scans to obtain an accurate representation of the new bone formation between the vertebrae (55) (Fig. 1D) . Morphometric parameters were then computed from the binarized images using direct 3D techniques (marching cubes and spherefitting methods), and included bone mineral density (BMD, g/cm 3 ), and bone volume (BV, mm 3 ) (Fig. 1D) . All quantitative and structural parameters followed the nomenclature and units
recommended by the American Society for Bone and Mineral Research (ASBMR)
Histomorphometry Nomenclature Committee (56) . After data quantification, 3D rendered models were generated for the visualization of analyzed regions using the marching cubes method.
Histology and immunohistochemistry on decalcified tissue
After decalcification in 19% ethylenediaminetetraacetic acid, the samples were embedded in paraffin. H&E and immunohistochemistry for bone sialoprotein (BSP) (Chemicon) were performed as previously described (57) .
Bone dynamic labeling and hPSCs tracking on undecalcified tissue
To visualize bone-forming activity, the selected animals were injected with Calcein/Alizarin prior to sacrifice. Frozen sections were cut following Kawamoto's procedure (58) .
Immunofluorescent staining for human-specific major histocompatibility complex (hMHC) class I antigen (Santa Cruz Biotechnology) was performed and analyzed using the Olympus image system.
Statistics
A paired t-test was used to test significance when only two groups were tested after normality test. Kruskal-Wallis test with post-hoc tests of Bonferroni was used to test the significance of data to compare more than two groups. The statistical software, SPSS for Windows Version 18.0 (SPSS, Chicago, IL, USA) was used for all statistical analyses. Statistical significance was determined p<0.05.
Results
Similar osteogenic capacity of hPSCs from osteoporotic and non-osteoporotic conditions
No significant difference in osteogenic differentiation was observed between the healthy and osteoporotic donors. Interestingly, the addition of NELL-1 enhanced mineralization of hPSCs 13 from both types of donors without significant differences (Fig. 2) . The additional experiment under adipogenic induction revealed that, in contrast to BMP-2, hPSCs treated with NELL-1 did not undergo more adipogenic differentiation compared to PBS control (p>0.05), although hPSCs from osteoporotic donors displayed inherently higher adipogenic differentiation compared to its healthy counterpart (Fig. 2) . Notably, the average yield of hPSCs from listed donors did not differ significantly from each other ( Table 1 ).
hPSC+NELL-1 increased fusion rate in the osteoporotic rats
Post-OVX, the average BMD of the L5 vertebrae significantly decreased by 10.2% compared to its preoperative state (p<0.01) (Fig. 3) . Among seven groups, High P+N group exhibited significantly increased palpation scores (4.7) with the highest fusion rate at 83.3% ( Fig.   4F ) compared to the other study groups (p<0.01) (Fig. 4A, 4B, 4C, 4D, 4E) . Notably, neither the regular dose which was effective for healthy rats (44, 54) nor high dose of hPSCs or NELL-1 alone could produce a significant fusion rate in OVX rats ( Table 2) , with only 20% fusion rate in Regular NELL-1, regular hPSCs and high NELL-1 groups while high hPSCs fusion rate was 28.6% ( Fig.   4A, 4B, 4C, 4D ).
Robust bone formation promoted by hPSC+NELL-1 in the osteoporotic rats
Three dimensional micro-CT images showed that High P+N formed new bony masses between the transverse processes resulting in solid fusion. In contrast, the control group demonstrated clear clefts between the two transverse processes with minimal bone formation.
Quantitatively, the High P+N group exhibited a significant increase in BV of 82.6±1.97 mm 3 compared to any other groups (p<0.01) (Fig. 5) . However, the samples with regular dose did not exhibit a significant difference (Fig. 7) . Histologically, the fibrous tissue formation was prevalent in the control, High N and High P samples. In contrast, we observed large areas of chondroid matrix with bone formation, increased vascularization and complete bony bridging in High P+N specimens. Additionally, BSP immunohistochemistry demonstrated increased staining in new bone and cartilaginous tissue in High P and High P+N samples compared to the control samples. (Fig. 6A) .
Tissue engraftment revealed involvement of hPSCs in active ossification
We observed a wider band of Calcein/Alizarin labeling in High P+N than other groups, suggesting more robust active ossifications along the edges of the dimeneralized bone matrix (Fig.   6B) . We merged the images of hMHC Class I immunofluorescent staining with Calcein/Alizarin labeling and found that hPSCs and new bone formation were co-located in the same region, confirming the direct involvement of hPSCs in situ of the active ossification (Fig. 6C) .
Discussion
One of the most promising emerging surgical options maybe the use of "composite graft"
that comprise osteogenic capacity with osteoinduction properties along with osteoconductive scaffold. Recent developments in regenerative medicine support the crucial role that stem cells play in bone regeneration. However, most studies are designed using a healthy animal to create disease models (44, 69) . In order to replicate clinical osteoporotic settings, it becomes critical to demonstrate the efficacy of these stem cell therapeutics in osteoporotic animals. To our knowledge, this is the first study that clearly demonstrated the great potential of combinatorial application of stem cells (hPSCs) and osteogenic factor (NELL-1) in promoting successful spinal fusion in osteoporotic rats.
Although not yet fully understood, delayed fusion or nonunion in osteoporotic bone have been attributed to: (1) decreased proliferation and differentiation capacity of endogenous 15 mesenchymal stem cells; (2) diminished formation of vasculature; (3) lower osteoinductive activity; and (4) changes in local and systemic signaling molecules (59) .
In agreement with prior studies, we observed that the healing potency of osteoporotic bone was severely impaired compared to its healthy counterpart (Table 4 ) (60) (61) (62) (63) (64) . Only 20% of fusion was achieved in osteoporotic rats using the same number (0.25x10 6 cells/ml, regular dose) of hPSCs that induced 100% fusion in non-osteoporotic rats (44) .
It was reported that stem cells from fat, even from osteoporotic patients, can undergo osteogenic differentiation at a similar rate to bone marrow stem cells (BMSCs) from younger patients (70) . Our study revealed similar osteogenic capacity of hPSCs from lipoaspirate between donors with and without osteoporosis. Considering the defects in osteogenic property of BMSCs from osteoporotic condition (71) , these characteristics of hPSCs will be a good building block in the development of efficacious and safe therapy using autologous stem cells from adipose tissue in an orthopaedic clinical setting. The hPSCs induce bone formation via both direct osteogenic differentiation and indirect trophic effects. They secrete high levels of pro-osteogenic, provasculogenic growth factors, such as vascular endothelial growth factor, fibroblast growth factor 2, and epidermal growth factor (33, 43) .
There are several advantages to using NELL-1 in osteoporotic conditions over BMP-2: (1) NELL-1 inhibits BMP-2 induced inflammation by acting as an anti-inflammatory molecule (67) .
(2) NELL-1 has anti-osteoclastic effects (42) . (3) NELL-1 inhibits adipogenic differentiation (68) . In previous studies (65) , we observed NELL-1 could stimulate proliferation of hPSCs. Consequently, we suggest that the administration of hPSCs+NELL-1 restores the reduced native osteoprogenitor cell and osteoinductive microenvironment in osteoporotic bone. In the current study, the direct 16 involvement of hPSCs in active ossification was further validated by a novel cryostat sectioning technique using undecalcified samples.
However, further studies with larger sample size focusing on the mode of action of this promising therapy and on any differences of osteogenic capacities of hPSCs from obese and slim donors are warranted. It is unclear if differences in body mass index translate to differences in hPSC behavior, as has been previously reported in adipose derived stem cells (66) . The synergistic effects of hPSCs and NELL-1 in enhancing spinal fusion with osteoporotic condition shed light on possibility of developing hPSCs based therapy for osteoporotic patients.
Conclusion
Human adipose tissue derived hPSCs from both non-osteoporotic and osteoporotic conditions exhibited similar osteogenic capacity and responsiveness to osteoinductive factor in vitro. The hPSC combined with NELL-1 synergistically enhances spinal fusion in osteoporotic rats and has great potential as a novel therapeutic strategy for osteoporotic patients. a Regular P or regular N means that number of hPSCs or concentration of NELL-1 that demonstrates the successful fusion in non-osteoporotic models (44, 54) . High P or high N means the three times higher number of hPSCs compared to regular P or two times higher concentration of Figure 1A . MicroCT DataViewer software for sample alignment in all 3 planes-coronal, sagittal and transverse. The figure shows the sample aligned parallel to the coronal (arrow1) and sagittal (arrow2) sections before being analyzed and quantified. 
